You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 7, July 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book and Software Reviews
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Textbook of Ocular Pharmacology

edited by Thom J. Zimmerman, MD, PhD, Karanjit S. Koonere, MD, Robert D. Fechtner, MD, and Mordechai Sharir, MD, PhD, 928 pp, with illus, $175, ISBN0-781-70306-9, Hagerstown, Md, Lippincott-Raven Publishers, 1997.

Arch Ophthalmol. 1999;117:989.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This comprehensive, in-depth, inclusive, Textbook of Ocular Pharmacology is excellent. The authors have divided the 73 chapters into 8 sections. The books' greatest use will be for a one-stop reference to answer any question regarding pharmacology of the eye.

The first section covers all of the general aspects of ocular pharmacology. Contained in here are excellent chapters about pharmacodynamics, of drug receptor interactions, drug reactions not mediated by receptors, and includes a chapter on drug delivery systems. The chapter regarding drug delivery systems is an example of the editors' devotion to including subjects that are seeing great strides and improvement and continued change.

Section 2, the glaucoma section, is perhaps the best section, with all chapters well organized in an identical fashion. Again, the chapter regarding the future role of neuroprotective agents in glaucoma, is an example of the editors' desire to be as current as possible.

In section 3, . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.